Abstract
Aim:
The aim of the present study was to investigate the effects of silencing the livin gene by small interfering RNA (siRNA) on the expression of livin and the effects on apoptosis, cell cycle, and proliferation in human malignant melanoma LiBr cells.
Methods:
Three chemically-synthetic siRNA duplexes targeting livin were transiently transfected into the LiBr cells, and the effects on livin expression were detected both at the mRNA level by real-time RT-PCR and at the protein level by Western blotting. Apoptosis was evaluated by terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP nick-end labeling assay, flow cytometric analysis, and the expression of procaspase-3 and activated caspase-3 analysis by Western blotting. Cell cycle was analyzed by flow cytometry. Cell proliferation was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
Results:
One of the 3 designed siRNA could effectively knock down the livin expression both at the mRNA and protein levels in dose- and time-dependent manners; 100 nmol/L with maximum downregulation on mRNA at 48 h, and on the protein at 72 h after transfection. Silencing livin could significantly induce apoptosis, arrest cell cycle at the G0/G1 phase, and inhibit proliferation in LiBr cells. Meanwhile, caspase-3 was activated.
Conclusion:
The livin gene could serve as a potential molecular target for gene therapy by siRNA for malignant melanoma.
Similar content being viewed by others
Article PDF
References
Kasof GM, Gomes BC . Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001; 276: 3238–46.
Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM . ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000; 10: 1359–66.
Lin JH, Deng G, Huang Q, Morser J . KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2000; 279: 820–31.
Liu B, Han M, Wen JK, Wang L . Livin/ML-IAP as a new target for cancer treatment. Cancer Lett 2007; 250: 168–76.
Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, et al. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res 2003; 63: 6340–9.
Gong J, Chen N, Zhou Q, Yang B, Wang Y, Wang X . Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and meta-static melanomas. J Clin Pathol 2005; 58: 1081–5.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–8.
Izquierdo M . Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 2005; 12: 217–27.
Li CY, Gao TW, Wang G, Han Z Y, Li TH, Liu YF . The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells. Br J Dermatol 2004; 150: 1081–90.
Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A . Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326–30.
Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D, Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 2001; 495: 56–60.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2−??Ct method. Methods 2001; 25: 402–8.
Du Y, Yin F, Liu C, Hu S, Wang J, Xie H, et al. Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Biochem Biophys Res Commun 2006; 345: 1092–8.
Zhang HZ, Wang Y, Gao P, Lin F, Liu L, Yu B, et al. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells. Cancer Biol Ther 2006; 5: 1457–61.
Nachmias B, Ashhab Y, Ben-Yehuda D . The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004; 14: 231–43.
Fischer U, Schulze-Osthoff K . New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev 2005; 57: 187–215.
Kumar S . Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32–43.
Kumar MV, Shirley R, Ma Y, Lewis RW . Role of genomics-based strategies in overcoming chemotherapeutic resistance. Curr Pharm Biotechnol 2004; 5: 471–80.
Shi Y . Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci 2004; 13: 1979–87.
Namkoong J, Martino JJ, Chen S . From existing therapies to novel targets: a current view on melanoma. Front Biosci 2006; 11: 2081–92.
Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H . Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 2002; 30: 1757–66.
Crnkovic-Mertens I, Hoppe-Seyler F, Butz K . Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ ML-IAP/KIAP gene. Oncogene 2003; 22: 8330–6.
Evan GI, Vousden KH . Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–8.
Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S . Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39–85.
Pietenpol JA, Stewart ZA . Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002; 181–182: 475–81.
Zhou BB, Elledge SJ . The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433–9.
Nyberg KA, Michelson RJ, Putnam CW, Weinert TA . Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002; 36: 617–56.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, H., Tan, Ss., Wang, Xy. et al. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Acta Pharmacol Sin 28, 1968–1974 (2007). https://doi.org/10.1111/j.1745-7254.2007.00724.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00724.x
Keywords
This article is cited by
-
Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells
Journal of Pharmacokinetics and Pharmacodynamics (2015)
-
Research progress on Livin protein: an inhibitor of apoptosis
Molecular and Cellular Biochemistry (2011)
-
Livin abrogates apoptosis of SPC-A1 cell by regulating JNKI signaling pathway
Molecular Biology Reports (2010)